+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Testosterone Replacement Therapy Market 2020-2024- Product Image
Global Testosterone Replacement Therapy Market 2020-2024- Product Image

Global Testosterone Replacement Therapy Market 2020-2024

  • ID: 5188692
  • Report
  • October 2020
  • Region: Global
  • 120 pages
  • TechNavio

FEATURED COMPANIES

  • AbbVie Inc.
  • Antares Pharma Inc.
  • Bayer AG
  • Clarus Therapeutics Inc.
  • Eli Lilly and Co.
  • Endo International Plc
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Testosterone Replacement Therapy Market 2020-2024

The publisher has been monitoring the testosterone replacement therapy market and it is poised to grow by $ 113.54 mn during 2020-2024, progressing at a CAGR of 1% during the forecast period. The reports on the testosterone replacement therapy market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by initiatives to increase awareness of diseases and untapped potential in developing countries. In addition, initiatives to increase awareness of diseases is anticipated to boost the growth of the market as well.

The testosterone replacement therapy market analysis includes product segment and geographical landscapes.

The testosterone replacement therapy market is segmented as below:

By Product
  • Injectables
  • Topicals
  • Others
By Geographic Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the rise in chronic diseases as one of the prime reasons driving the testosterone replacement therapy market growth during the next few years.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The testosterone replacement therapy market report covers the following areas:
  • Testosterone replacement therapy market sizing
  • Testosterone replacement therapy market forecast
  • Testosterone replacement therapy market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading testosterone replacement therapy market vendors that include AbbVie Inc., Acerus Pharmaceuticals Corp., Antares Pharma Inc., Bayer AG, Clarus Therapeutics Inc., Eli Lilly and Co., Endo International Plc, Ferring Pharmaceuticals AS, Novartis AG, and Pfizer Inc. Also, the testosterone replacement therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Antares Pharma Inc.
  • Bayer AG
  • Clarus Therapeutics Inc.
  • Eli Lilly and Co.
  • Endo International Plc
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Market characteristics
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Fiver forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Injectables - Market size and forecast 2019-2024
  • Topicals - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by Product
Customer Landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Vendor landscape
  • Landscape disruption
  • Competitive scenario
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • Acerus Pharmaceuticals Corp.
  • Antares Pharma Inc.
  • Bayer AG
  • Clarus Therapeutics Inc.
  • Eli Lilly and Co.
  • Endo International Plc
  • Ferring Pharmaceuticals AS
  • Novartis AG
  • Pfizer Inc.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
Exhibit
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2019 - 2024 ($ million)
  • Global market: Year-over-year growth 2019 - 2024 (%)
  • Five forces analysis 2019 & 2024
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2019
  • Product - Market share 2019-2024 (%)
  • Comparison by Product
  • Injectables - Market size and forecast 2019-2024 ($ million)
  • Injectables - Year-over-year growth 2019-2024 (%)
  • Topicals - Market size and forecast 2019-2024 ($ million)
  • Topicals - Year-over-year growth 2019-2024 (%)
  • Others - Market size and forecast 2019-2024 ($ million)
  • Others - Year-over-year growth 2019-2024 (%)
  • Market opportunity by Product
  • Customer landscape
  • Market share by geography 2019-2024 (%)
  • Geographic comparison
  • North America - Market size and forecast 2019-2024 ($ million)
  • North America - Year-over-year growth 2019-2024 (%)
  • Europe - Market size and forecast 2019-2024 ($ million)
  • Europe - Year-over-year growth 2019-2024 (%)
  • Asia - Market size and forecast 2019-2024 ($ million)
  • Asia - Year-over-year growth 2019-2024 (%)
  • ROW - Market size and forecast 2019-2024 ($ million)
  • ROW - Year-over-year growth 2019-2024 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Business segments
  • AbbVie Inc. - Key offerings
  • AbbVie Inc. - Key customers
  • AbbVie Inc. - Segment focus
  • Acerus Pharmaceuticals Corp. - Overview
  • Acerus Pharmaceuticals Corp. - Business segments
  • Acerus Pharmaceuticals Corp. - Key offerings
  • Acerus Pharmaceuticals Corp. - Key customers
  • Acerus Pharmaceuticals Corp. - Segment focus
  • Antares Pharma Inc. - Overview
  • Antares Pharma Inc. - Business segments
  • Antares Pharma Inc. - Key offerings
  • Antares Pharma Inc. - Key customers
  • Antares Pharma Inc. - Segment focus
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key offerings
  • Bayer AG - Key customers
  • Bayer AG - Segment focus
  • Clarus Therapeutics Inc. - Overview
  • Clarus Therapeutics Inc. - Product and service
  • Clarus Therapeutics Inc. - Key offerings
  • Clarus Therapeutics Inc. - Key customers
  • Clarus Therapeutics Inc. - Segment focus
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Business segments
  • Eli Lilly and Co. - Key offerings
  • Eli Lilly and Co. - Key customers
  • Eli Lilly and Co. - Segment focus
  • Endo International Plc - Overview
  • Endo International Plc - Business segments
  • Endo International Plc - Key offerings
  • Endo International Plc - Key customers
  • Endo International Plc - Segment focus
  • Ferring Pharmaceuticals AS - Overview
  • Ferring Pharmaceuticals AS - Product and service
  • Ferring Pharmaceuticals AS - Key offerings
  • Ferring Pharmaceuticals AS - Key customers
  • Ferring Pharmaceuticals AS - Segment focus
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key offerings
  • Novartis AG - Key customers
  • Novartis AG - Segment focus
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Key customers
  • Pfizer Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Antares Pharma Inc.
  • Bayer AG
  • Clarus Therapeutics Inc.
  • Eli Lilly and Co.
  • Endo International Plc
The publisher recognizes the following companies as the key players in the global testosterone replacement therapy market: AbbVie Inc., Acerus Pharmaceuticals Corp., Antares Pharma Inc., Bayer AG, Clarus Therapeutics Inc., Eli Lilly and Co., Endo International Plc, Ferring Pharmaceuticals AS, Novartis AG, and Pfizer Inc.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the rise in chronic diseases.'

According to the report, one of the major drivers for this market is the initiatives to increase awareness of diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
  • AbbVie Inc.
  • Acerus Pharmaceuticals Corp.
  • Antares Pharma Inc.
  • Bayer AG
  • Clarus Therapeutics Inc.
  • Eli Lilly and Co.
  • Endo International Plc
  • Ferring Pharmaceuticals AS
  • Novartis AG
  • Pfizer Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll